Journal of Integrative Oncology

ISSN: 2329-6771

Open Access

Lysophosphatidic Acid- A Target in Ovarian and Endometrial Cancer Therapy


Tomasz Waśniewski, Joanna Staszkiewicz and Izabela Wocławek-Potocka

Lysophosphatidic acid (LPA), one of the simplest and most potent lysophospholipids exerting many physiological and pathological actions on various cell types, plays also an essential role in tumorigenesis and cancer metastasis. Overexpression of LPA and its receptors is a common phenomenon in metastatic carcinomas that can be used in new diagnostics strategies. Both, in the ovarian and endometrial cancer cells, LPA activates various signal transduction pathways, leading to the increased proliferation and metastatic abilities of the cells. In this review we would like to prove that development of potential treatment strategies by targeting LPA has a great promise in therapeutics.


Share this article

Google Scholar citation report
Citations: 478

Journal of Integrative Oncology received 478 citations as per Google Scholar report

Journal of Integrative Oncology peer review process verified at publons

Indexed In

arrow_upward arrow_upward